FBI-1 enhanced the resistance of triple-negative breast cancer cells to chemotherapeutic agents via the miR-30c/PXR axis
Hua Yang(Nanjing Agricultural University), Guanghai Dai(Chinese PLA General Hospital), Yaning Wei(Affiliated Hospital of Hebei University), Yumiao Li(Affiliated Hospital of Hebei University), Aimin Zang, Yanan Wang, Yang Yang(Zhongyuan University of Technology), Qian Zhang(Jiangsu Province Hospital), Xiaoli Li(Fujian Medical University), Youchao Jia(Affiliated Hospital of Hebei University), Xuebing Bi, Ming Wen(Affiliated Hospital of Hebei University), Lili Ren(Nanjing Tech University)
Cited by 42
Related Papers
Roles of circRNAs in the tumour microenvironment
|Molecular Cancer|2020|281
The Physiologic Role of CD19 Cytoplasmic Tyrosines
|Immunity|2002|145
Quercetin Ameliorates Diabetic Kidney Injury by Inhibiting Ferroptosis via Activating Nrf2/HO-1 Signaling Pathway
|The American Journal of Chinese Medicine|2023|141
MiR-103a-3p promotes tumour glycolysis in colorectal cancer via hippo/YAP1/HIF1A axis
|Journal of Experimental & Clinical Cancer Research|2020|139
Inflammation: A Novel Therapeutic Target/Direction in Atherosclerosis
|Current Pharmaceutical Design|2017|132